Max Robotics — Global Service Robot Directory + US Certification

About

David Robinson is a prominent researcher specializing in urological oncology, with a particular focus on prostate cancer treatment outcomes, surgical techniques, and patient quality of life. Working extensively with Sweden's National Prostate Cancer Register, Robinson has made substantial contributions to understanding the real-world consequences of radical prostatectomy and radiotherapy in large, population-based cohorts. His most impactful work examines patient-reported side effects following curative prostate cancer treatments, including urinary symptoms, bowel disturbances, erectile dysfunction, and psychological wellbeing. His 2024 study on post-treatment side effects has already garnered 33 citations, reflecting its immediate relevance to clinicians and researchers alike. Robinson has also conducted critical comparative analyses between robot-assisted and retropubic radical prostatectomy, illuminating long-term adverse effects and postoperative mortality rates across nationwide Swedish populations — work that has collectively accumulated dozens of citations and directly informed surgical quality benchmarking. A key contributor to the Prostatectomies in Sweden (PiS) registry initiative, Robinson has helped establish robust infrastructures for quality assurance in urological surgery. His research consistently bridges large-scale epidemiological data with clinically meaningful patient outcomes, making him an authoritative voice in evidence-based prostate cancer care.